Increasing Role of Medication Therapy for Managing Student Behavior

American Academy of Child and Adolescent Psychiatry. (2009). Practice parameters on the use of psychotropic medication in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 48, 961–973.

American Academy of Pediatrics (AAP). (2009). Policy statement. Guidance for the administration of medication in school. Pediatrics, 124, 1244–1251.

American Academy of Pediatrics (AAP). (2011). ADHD: Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics, 128(5), 1–16.

Bradley C. (1937). The behavior of children receiving Benzendrine. American Journal of Psychiatry, 94, 577–585.

Centers for Disease Control, and Prevention. (2013). Facts About ASDs. Internet site: http://www.cdc.gov/ncbddd/autism/facts.html

Center for Health and Health Care in Schools. (2007). Psychotropic drugs and children: A 2007 update. Washington, DC: The School of Public Health and Health Services, The George Washington University. Internet site: http://www.healthinschools.org/~/media/1F79BC0050C64BF9B79EAB1FD0A21D21.ashx

Connor D. F. , Boone R. T. , Steingard R. J. , Lopez I. D. , & Melloni R. H. (2003). Psychopharmacology and aggression: II. A meta-analysis of nonstimulant medication effects on overt aggression-related behaviors in youth with SED. Journal of Emotional and Behavioral Disorders, 11, 157–168.

Costello E. J. , He J. , Sampson N. A. , Kessler R. C. , & Merikangas K. R. (2014). Services for adolescents with psychiatric disorders: 12-month data from the National Comorbidity Survey–Adolescent. Psychiatric Services, 65(3), 359–366.

Coury D. L. , Anagnostou E. , Manning-Courtney P. , Reynolds A. , Cole L. , McCoy R. , …, & Perris J. M. (2012). Use of psychotropic medication in children and adolescents with autism spectrum disorders. Pediatrics, 130, S69–S76.

DuPaul G. J. , Power T. J. , Anastopoulos A. D. , & Reid R. (1998). The ADHD rating scale–IV: Checklists, norms, and clinical interpretation. New York, NY: Guilford Press.

Forness S. R. (2011). Special education and the new mental health. Behavioral Disorders, 37, 41–46.

Forness S. R. , Freeman S. F. , & Paparella T. (2006). Recent randomized clinical trials comparing behavioral interventions and psychopharmacologic treatments for students with EBD. Behavioral Disorders, 31, 284–296.

Forness S. R. , Kavale K. A. , & Davanzo P. A. (2002). The new medical model: Interdisciplinary treatment and the limits of behaviorism. Behavioral Disorders, 27(2), 168–178.

Gureasko-Moore D. , DuPaul G. J. , & Power T. (2005). Stimulant treatment for attention-deficit/hyperactivity disorder: Medication monitoring practices of school psychologists. School Psychology Review, 34, 232–245.

Individuals with Disabilities Education Improvement Act of 2004 (IDEA), 20 U.S.C. §1400 et seq. (2004). Reauthorization of the Individuals with Disabilities Education Act of 1990.

Kratochvil C. J. (2010). The issue: Pediatric and adolescent psychopharmacology. Psychiatric Annals, 40(4), 179–180.

McIntyre R. S. , & Jerrell J. M. (2009). Polypharmacy in children and adolescents treated for major depressive disorder: A claims database study. Journal of Clinical Psychiatry, 70(2), 240–246.

Morris J. P. , & Stone G. (2011). Children and psychotropic medication: A cautionary note. Journal of Marital and Family Therapy, 37, 299–306.

Oswald D. P. (2002). The new medical model and beyond: A response to Forness and Kavale. Behavioral Disorders, 27, 155–157.

Ryan J. B. , & Katsiyannis A. (2009). The importance of teacher involvement in medication therapy. TEACHING Exceptional Children Plus, 6(2) Article 1. Internet site: http://static1.1.sqspcdn.com/static/f/1267826/18215789/1337101811063/Importance_of_Teacher_Involvement_in_Medication_Therapy.pdf?token=LXGerFciB8Cj1NIHdnQt%2BHckjwU%3D

Ryan J. B. , Katsiyannis A. , & Hughes E. (2011). Medication treatment for attention deficit hyperactivity disorder. Theory Into Practice, 50(1), 1–9.

Ryan J. B. , Katsiyannis A. , Losinski M. , Reid R. , & Ellis C. (2014). Review of state medication policies/guidelines regarding psychotropic medications in public schools. Journal of Child and Family Studies, 23(4), 704–715.

Ryan J. B. , Reid R. , & Ellis C. (2008). A survey of special educator knowledge regarding psychotropic interventions for students with emotional and behavioral disorders. Remedial and Special Education, 29(5), 269–279.

Ryan J. B. , Reid R. , Epstein M. H. , Ellis C. , & Evans J. H. (2005). Pharmacological interventions research for academic outcomes for students with ADHD. Behavioral Disorders, 30(2), 135–154.

Ryan J. B. , Reid R. , Gallagher K. , & Ellis C. (2008). Prevalence rates of psychotropic medications for students placed in residential care. Behavioral Disorders, 33(2), 99–107.

Rehabilitation Act of. 1973, § 504, 34 C.F.R. Part 104, Subpart D-Preschool, Elementary, and Secondary Education. Internet site: http://www.ed.gov/policy/rights/reg/ocr/edlite-34cfr104.html#E

Stahl S. M. (2013). Stahl's essential psychopharmacology (4th ed.). San Diego, CA: Cambridge University Press.

Swanson J. M. (1992). School-based assessments and interventions for ADD students. Irvine, CA: KC Publishing.

U.S. Food and Drug Administration (2007, May 2). Antidepressant Use in Children, Adolescents, and Adults. Internet site: http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/UCM096273

Zito J. M. , Derivan A. T. , Kratochvil C. J. , Safer D. J. , Fegert J. M. , & Greenhill L. L. (2008). Off-label psychopharmacologic prescribing for children: History supports close clinical monitoring. Child and Adolescent Psychiatry and Mental Health, 2, 24. Advance online publication. doi: 10.1186/1753-2000-224 PMCID: PMC2566553

Zito J. M. , Safer D. J. , dosReis S. , Gardner J. F. , Boles M. , & Lynch F. (2000). Trends in the prescribing of psychotropic medications to preschoolers. Journal of the American Medical Association, 283, 1025–1030.